Bioventure

Bioventure is a leading UAE-based biopharmaceutical company dedicated to delivering world-class healthcare solutions throughout the Middle East and beyond. Specializing in Biotech and Generics Commercialization, Tech Transfer, and In/Out-licensing activities, Bioventure is committed to enhancing access to innovative and affordable medicines. Bioventure leverages a strong global network and strategic partnerships to bring cutting-edge pharmaceutical products to the region.

With a focus on improving patient outcomes, Bioventure holds an equity stake in Alvotech and has an exclusive distribution and commercialization agreement for Alvotech’s biosimilar portfolio across the Middle East and Africa. Furthermore, Bioventure enjoys exclusive partnership and distribution rights for Alvogen’s targeted Generic pharmaceuticals portfolio across the MENA region, encompassing 28 generic pharmaceuticals in Oncology, Autoimmune and Inflammation, and Blood Disease. The primary address for Bioventure is in Dubai, AE.

Bioventure is poised for continued growth and success, driven by its commitment to excellence and its dedication to meeting the evolving healthcare needs of the region. We invite the manager of Bioventure to create a customized and exclusive company showcase and product listing on our platform to further amplify their market presence and connect with new opportunities.